The adaptor protein CIN85 assembles intracellular signaling clusters for B cell activation.
Kuhn, J., Wong, L.E., Pirkuliyeva, S., Schulz, K., Schwiegk, C., Funfgeld, K.G., Keppler, S., Batista, F.D., Urlaub, H., Habeck, M., Becker, S., Griesinger, C., Wienands, J.(2016) Sci Signal 9: ra66-ra66
- PubMed: 27353366 
- DOI: https://doi.org/10.1126/scisignal.aad6275
- Primary Citation of Related Structures:  
2N64, 5ABS - PubMed Abstract: 
The adaptor molecule Cbl-interacting protein of 85 kD (CIN85) regulates signaling from a number of cell surface receptors, such as growth factor receptors and antigen receptors on lymphocytes. Because of its multidomain structure, CIN85 is thought to act as a classical adaptor protein that connects functionally distinct components of a given signaling pathway through diverse protein domains. However, we found that in B lymphocytes, CIN85 functions to oligomerize SLP-65, which is the central effector protein of the B cell receptor (BCR). Therefore, CIN85 trimerizes through a carboxyl-terminal, coiled-coil domain. The multiple Src homology 3 (SH3) domains of trimeric CIN85 molecules associated with multiple SLP-65 molecules, which recruited further CIN85 trimers, thereby perpetuating the oligomerization process. Formation of this oligomeric signaling complex in resting B cells rendered the cells poised for the efficient initiation of intracellular signaling upon BCR stimulation. Our data suggest that the functionality of signaling cascades does not rely solely on the qualitative linkage of their various components but requires a critical number of effectors to become concentrated in signaling complexes.
Organizational Affiliation: 
Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Humboldtallee 34, 37073 Göttingen, Germany.